Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000569300

Apexbio Technology LLC GSK8612-100MG
SDP

Catalog No. 5000569300
Encompass_Preferred

GSK8612 (CAS No 2361659-62-1) is a selective inhibitor commonly studied within the biomedical research community Originating from glucocorticoid receptor modulation research its primary mechanism of action involves targeting the BET (bromodomain and extra-terminal) family of proteins which are crucial in regulating gene expression GSK8612 exhibits potent in vitro activity typically within the nanomolar to low micromolar range making it a valuable tool for investigating epigenetic regulation Its research applications often include cell models to study inflammatory responses and diseases such as cancer as well as animal studies to explore therapeutic potential Drug screening projects frequently incorporate GSK8612 to identify novel treatments that leverage its pathway modulation Experimental concentrations typically depend on the specific research design highlighting its adaptability and importance in developing targeted therapies

Catalog No. 50-005-69300 Supplier Apexbio Technology LLC Supplier No. BA8599100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GSK8612 (CAS No 2361659-62-1) is a selective inhibitor commonly studied within the biomedical research community Originating from glucocorticoid receptor modulation research its primary mechanism of action involves targeting the BET (bromodomain and extra-terminal) family of proteins which are crucial in regulating gene expression GSK8612 exhibits potent in vitro activity typically within the nanomolar to low micromolar range making it a valuable tool for investigating epigenetic regulation Its research applications often include cell models to study inflammatory responses and diseases such as cancer as well as animal studies to explore therapeutic potential Drug screening projects frequently incorporate GSK8612 to identify novel treatments that leverage its pathway modulation Experimental concentrations typically depend on the specific research design highlighting its adaptability and importance in developing targeted therapies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.